Long-Term Effect of Dipeptidyl Peptidase-IV Inhibitors on Cardiovascular Events in Type 2 Diabetes Mellitus Middle-Age Patients: A Meta-Analysis

被引：0
|
作者：
Patel, Samir [1 ]
Patel, Palak [2 ]
Patel, Mihir [3 ]
机构：
[1] Western Reserve Hlth Educ, NEOMED, Youngstown, OH USA
[2] Qingdao Med Coll, Qingdao, Peoples R China
[3] St Marys Hosp, Waterbury, CT USA
来源：
ENDOCRINE REVIEWS | 2014年 / 35卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SAT-0971
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Glycaemic durability with dipeptidyl peptidase-4 inhibitors in type 2 diabetes: a systematic review and meta-analysis of long-term randomised controlled trials
    Esposito, Katherine
    Chiodini, Paolo
    Maiorino, Maria Ida
    Bellastella, Giuseppe
    Capuano, Annalisa
    Giugliano, Dario
    BMJ OPEN, 2014, 4 (06):
  • [32] Gastrointestinal Adverse Events of Dipeptidyl Peptidase 4 Inhibitors in Type 2 Diabetes: A Systematic Review and Network Meta-analysis
    Wu, Shanshan
    Chai, Sanbao
    Yang, Jun
    Cai, Ting
    Xu, Yang
    Yang, Zhirong
    Zhang, Yuan
    Ji, Linong
    Sun, Feng
    Zhan, Siyan
    CLINICAL THERAPEUTICS, 2017, 39 (09) : 1780 - 1789
  • [33] Direct head-to-head comparison of glycaemic durability of dipeptidyl peptidase-4 inhibitors and sulphonylureas in patients with type 2 diabetes mellitus: A meta-analysis of long-term randomized controlled trials
    Chen, Kang
    Kang, Deying
    Yu, Miao
    Zhang, Ruya
    Zhang, Ye
    Chen, Guojuan
    Mu, Yiming
    DIABETES OBESITY & METABOLISM, 2018, 20 (04): : 1029 - 1033
  • [34] Drug-induced bullous pemphigoid in diabetes mellitus patients receiving dipeptidyl peptidase-IV inhibitors plus metformin
    Skandalis, K.
    Spirova, M.
    Gaitanis, G.
    Tsartsarakis, A.
    Bassukas, I. D.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2012, 26 (02) : 249 - 253
  • [35] Dipeptidyl peptidase IV inhibitors and the risk of mycobacterial pulmonary infections in type 2 diabetes mellitus
    Wang, Cheng-Yi
    Liao, Kuang-Ming
    Wang, Ya -Hui
    Chen, Kuang-Hung
    Chuang, Shulin
    Liu, Chia-Jung
    Shu, Chin-Chung
    Wang, Hao-Chien
    JOURNAL OF INFECTION AND PUBLIC HEALTH, 2023, 16 (11) : 1709 - 1715
  • [36] Application of Incretin Mimetics and Dipeptidyl Peptidase IV Inhibitors in Managing Type 2 Diabetes Mellitus
    Boyle, Patrick J.
    Freeman, Jeffrey S.
    JOURNAL OF THE AMERICAN OSTEOPATHIC ASSOCIATION, 2007, 107 : S10 - S16
  • [37] Addition of dipeptidyl peptidase-4 inhibitors to insulin treatment in type 2 diabetes patients: A meta-analysis
    Yang, Wenjia
    Cai, Xiaoling
    Gao, Xueying
    Chen, Yifei
    Chen, Ling
    Ji, Linong
    JOURNAL OF DIABETES INVESTIGATION, 2018, 9 (04) : 813 - 821
  • [38] Dipeptidyl peptidase-4 inhibitors and cardiovascular events in patients with type 2 diabetes, without cardiovascular or renal disease
    Baksh, Sheriza N.
    Segal, Jodi B.
    McAdams-DeMarco, Mara
    Kalyani, Rita R.
    Alexander, G. Caleb
    Ehrhardt, Stephan
    PLOS ONE, 2020, 15 (10):
  • [39] Dipeptidyl peptidase 4 (DPP-4) inhibitors and cardiovascular outcomes in patients with type 2 diabetes mellitus (T2DM): a systematic review and meta-analysis
    Liu, Dan
    Jin, Biao
    Chen, Wei
    Yun, Peng
    BMC PHARMACOLOGY & TOXICOLOGY, 2019, 20 (1):
  • [40] Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Type 2 Diabetes: Meta-Analysis
    Park, Haesuk
    Park, Chanhyun
    Kim, Yoona
    Rascati, Karen L.
    ANNALS OF PHARMACOTHERAPY, 2012, 46 (11) : 1453 - 1469
12345